Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metal Nanoparticles | 4 | 2018 | 405 | 1.020 |
Why?
|
| Gold | 3 | 2018 | 484 | 0.960 |
Why?
|
| Tryptamines | 2 | 2016 | 88 | 0.660 |
Why?
|
| Gels | 5 | 2019 | 427 | 0.630 |
Why?
|
| Alginates | 1 | 2019 | 252 | 0.620 |
Why?
|
| Microspheres | 1 | 2019 | 777 | 0.570 |
Why?
|
| Poloxamer | 1 | 2016 | 57 | 0.540 |
Why?
|
| Hydrogels | 1 | 2021 | 724 | 0.530 |
Why?
|
| Oxazolidinones | 1 | 2016 | 96 | 0.520 |
Why?
|
| Drug Delivery Systems | 3 | 2021 | 2219 | 0.410 |
Why?
|
| Chemistry, Pharmaceutical | 3 | 2016 | 281 | 0.380 |
Why?
|
| Temperature | 2 | 2016 | 2204 | 0.360 |
Why?
|
| Nanoparticles | 3 | 2023 | 1905 | 0.360 |
Why?
|
| Doxorubicin | 1 | 2016 | 2234 | 0.360 |
Why?
|
| Periodontium | 2 | 2018 | 99 | 0.300 |
Why?
|
| Biocompatible Materials | 1 | 2015 | 1736 | 0.290 |
Why?
|
| Materials Testing | 2 | 2018 | 867 | 0.240 |
Why?
|
| Pulmonary Surfactants | 1 | 2023 | 162 | 0.210 |
Why?
|
| Fibroblasts | 3 | 2018 | 4162 | 0.210 |
Why?
|
| Cell Survival | 3 | 2021 | 5882 | 0.180 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 2016 | 220 | 0.170 |
Why?
|
| Spheroids, Cellular | 1 | 2021 | 351 | 0.170 |
Why?
|
| Salacia | 1 | 2018 | 2 | 0.170 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2016 | 164 | 0.170 |
Why?
|
| Photochemical Processes | 1 | 2018 | 84 | 0.160 |
Why?
|
| Administration, Intranasal | 2 | 2016 | 446 | 0.150 |
Why?
|
| Vaccinium macrocarpon | 1 | 2017 | 12 | 0.150 |
Why?
|
| Acrylates | 1 | 2016 | 89 | 0.140 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2021 | 451 | 0.130 |
Why?
|
| Plant Extracts | 2 | 2016 | 471 | 0.130 |
Why?
|
| Ethanolamines | 1 | 2015 | 158 | 0.130 |
Why?
|
| Silver | 1 | 2016 | 122 | 0.130 |
Why?
|
| Microscopy, Atomic Force | 1 | 2015 | 250 | 0.130 |
Why?
|
| Serum Albumin, Bovine | 1 | 2015 | 324 | 0.130 |
Why?
|
| Fibrosarcoma | 1 | 2016 | 348 | 0.120 |
Why?
|
| Fluorenes | 1 | 2015 | 160 | 0.120 |
Why?
|
| Periodontitis | 1 | 2019 | 553 | 0.120 |
Why?
|
| Pyrrolidines | 1 | 2016 | 342 | 0.120 |
Why?
|
| Artemisinins | 1 | 2015 | 221 | 0.110 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 1678 | 0.110 |
Why?
|
| Cell Line | 3 | 2016 | 16000 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13693 | 0.110 |
Why?
|
| Serum Albumin | 1 | 2015 | 675 | 0.110 |
Why?
|
| Neoplasms | 1 | 2021 | 21696 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 2282 | 0.100 |
Why?
|
| Nanostructures | 1 | 2016 | 551 | 0.100 |
Why?
|
| Drug Carriers | 1 | 2015 | 693 | 0.100 |
Why?
|
| Dental Implants | 1 | 2018 | 750 | 0.090 |
Why?
|
| Cattle | 1 | 2015 | 3922 | 0.090 |
Why?
|
| Surface-Active Agents | 2 | 2023 | 159 | 0.090 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3590 | 0.080 |
Why?
|
| Antimalarials | 1 | 2015 | 905 | 0.080 |
Why?
|
| Animals | 10 | 2023 | 168768 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 2 | 2017 | 7182 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 2214 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 16690 | 0.070 |
Why?
|
| Bacteria | 1 | 2017 | 2115 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 4253 | 0.060 |
Why?
|
| Particle Size | 2 | 2020 | 1642 | 0.060 |
Why?
|
| Mice | 4 | 2023 | 81201 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10483 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 13104 | 0.040 |
Why?
|
| Therapeutic Irrigation | 1 | 2019 | 301 | 0.040 |
Why?
|
| Liposomes | 1 | 2020 | 759 | 0.040 |
Why?
|
| Lythraceae | 1 | 2016 | 7 | 0.030 |
Why?
|
| Silver Nitrate | 1 | 2016 | 12 | 0.030 |
Why?
|
| Green Chemistry Technology | 1 | 2016 | 9 | 0.030 |
Why?
|
| Wettability | 1 | 2015 | 24 | 0.030 |
Why?
|
| Drug Storage | 1 | 2015 | 51 | 0.030 |
Why?
|
| Polymers | 1 | 2023 | 1621 | 0.030 |
Why?
|
| Drug Stability | 1 | 2015 | 291 | 0.030 |
Why?
|
| Humans | 8 | 2021 | 744366 | 0.030 |
Why?
|
| Viscosity | 1 | 2015 | 328 | 0.030 |
Why?
|
| Biological Availability | 1 | 2015 | 397 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2016 | 274 | 0.030 |
Why?
|
| Crystallization | 1 | 2015 | 525 | 0.030 |
Why?
|
| Drug Compounding | 1 | 2015 | 242 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2016 | 712 | 0.030 |
Why?
|
| Solubility | 1 | 2015 | 1088 | 0.030 |
Why?
|
| Sheep | 1 | 2016 | 1437 | 0.030 |
Why?
|
| Nasal Mucosa | 1 | 2016 | 373 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2015 | 1892 | 0.030 |
Why?
|
| Rats | 2 | 2020 | 24252 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 1375 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2015 | 1655 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2015 | 1958 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2016 | 1877 | 0.020 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2016 | 687 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2016 | 1219 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2015 | 3914 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2016 | 1453 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2015 | 5077 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2023 | 21833 | 0.020 |
Why?
|
| Burns | 1 | 2016 | 1815 | 0.020 |
Why?
|
| Lung | 1 | 2023 | 9857 | 0.020 |
Why?
|
| Disease Progression | 1 | 2021 | 13286 | 0.020 |
Why?
|
| Male | 2 | 2016 | 350115 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2017 | 19233 | 0.010 |
Why?
|
| Prognosis | 1 | 2021 | 29060 | 0.010 |
Why?
|
| Female | 1 | 2016 | 380193 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 63107 | 0.010 |
Why?
|
Concepts
(101)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_